Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.

Purpose: To evaluate the efficacy and intermediate-term outcome of balloon-occluded retrograde transvenous obliteration (BRTO) for the treatment of hepatic encephalopathy (HE) secondary to portosystemic shunt (PSS) in cirrhotic patients.Materials and Methods: Institutional review board (IRB) approva...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 30; no. 6; pp. 3462 - 3473
Autores principales: Mukund, Amar, Chalamarla, Lakshmi Kumar, Singla, Nishant, Shasthry, Saggere Muralikrishna, Sarin, Shiv Kumar
Formato: research Journal Article
Publicado: Springer Nature Jun2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143397281&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143397281
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Jun2020
      vid: 30
      iid: 6
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        143397281
        143397281
        NLM32048037
        143397281
        10.1007/s00330-019-06644-4
        NLM32048037
        143397281
      ppf: 3462
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
      aug:
        au:
          Mukund, Amar
          Chalamarla, Lakshmi Kumar
          Singla, Nishant
          Shasthry, Saggere Muralikrishna
          Sarin, Shiv Kumar
        affil: Department of Radiology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, 110070, New Delhi, India
      sug:
        subj:
          Balloon Dilatation Methods
          Hypertension, Portal Complications
          Sclerosing Solutions Therapeutic Use
          Hepatic Encephalopathy Therapy
          Liver Cirrhosis Complications
          Splenic Vein
          Recurrence
          Survival
          Retrospective Design
          Female
          Renal Veins
          Tomography, X-Ray Computed
          Adult
          Esophageal and Gastric Varices Etiology
          Middle Age
          Treatment Outcomes
          Male
          Hepatic Encephalopathy Etiology
          Aged
          Human
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
          Male
      ab: Purpose: To evaluate the efficacy and intermediate-term outcome of balloon-occluded retrograde transvenous obliteration (BRTO) for the treatment of hepatic encephalopathy (HE) secondary to portosystemic shunt (PSS) in cirrhotic patients.Materials and Methods: Institutional review board (IRB) approval was obtained for this study and hospital records of patients who underwent BRTO, from August 2011 to August 2015, were analyzed. Based on the inclusion and exclusion criteria, 39 patients (age, 54.07 ± 9.1 years (37-67 years); 33 males and 6 females) with cirrhosis and spontaneous PSS were included. Clinical and laboratory parameters and HE grade were evaluated in all patients before and after the procedure.Results: Forty sessions of BRTO were attempted in 39 patients. Follow-up imaging revealed complete obliteration of the treated PSS in all patients with clinical success in 37 patients (94.9%). The 1-, 2-, 3-, 4-, 5-, 6-, and 7-year HE-free survival rates among responders were 91.7%, 91.7%, 88.8%, 85.5%, 80.8%, 80.8%, and 80.8% respectively and overall survival rates were 89.7%, 82.1%, 76.9%, 74.4%, 74.4%, 64.8%, and 64.8% respectively. Logistic regression highlighted Child-Turcotte-Pugh (CTP) score at 6 months as a positive predictive factor of HE recurrence with a cutoff of ≥ 9. Five patients (12.8%) had fever and leukocytosis and 1 (2.6%) patient developed spontaneous bacterial peritonitis after the procedure.Conclusion: BRTO is an effective treatment for refractory HE in cirrhotics secondary to large PSS with a few possible complications.Key Points: • BRTO is an effective and safe treatment for refractory HE, arising from PSS in cirrhotic patients. • Patients with preserved liver function show better outcome and CTP score is the most important predictor of relapse during follow-up.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N